ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,343,000 | -34.6% | 7,807 | -52.3% | 0.01% | -36.4% |
| Q2 2021 | $2,054,000 | +82.4% | 16,368 | +97.2% | 0.02% | +57.1% |
| Q1 2021 | $1,126,000 | +72.4% | 8,300 | +62.7% | 0.01% | +55.6% |
| Q4 2020 | $653,000 | -68.1% | 5,100 | -76.2% | 0.01% | -66.7% |
| Q2 2020 | $2,044,000 | +34.7% | 21,452 | -25.0% | 0.03% | -27.0% |
| Q4 2019 | $1,517,000 | +36.2% | 28,611 | +1.5% | 0.04% | +12.1% |
| Q3 2019 | $1,114,000 | -79.3% | 28,200 | -80.4% | 0.03% | -93.3% |
| Q3 2017 | $5,375,000 | +2050.0% | 144,017 | +1429.0% | 0.49% | +1864.0% |
| Q1 2017 | $250,000 | – | 9,419 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |